loading

Bridgebio Pharma Inc Azioni (BBIO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
11,999%
211.12
1.745 4.091 1.641 1.826
Cost Of Revenue
0.00%
0.598
0.598 0.598 0.599 0.651
Gross Profit
18,254%
210.52
1.147 3.493 1.042 1.175
Operating Expenses
17.71%
210.18
178.56 161.19 147.14 127.99
Interest Income/Expense
15.80%
23.47
20.27 20.31 20.59 20.12
Benefits Costs and Expenses
43.71%
247.28
172.07 183.58 162.34 144.56
Costs And Expenses
17.65%
210.78
179.16 161.78 147.74 127.99
Operating Income/Loss
100.19%
0.343
-177.42 -157.69 -146.10 -126.16
Nonoperating Income/Loss
615.00%
-36.50
7.088 -21.80 -14.60 -16.57
Income/Loss From Continuing Operations Before Tax
78.77%
-36.16
-170.33 -179.49 -160.70 -142.73
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
78.77%
-36.16
-170.33 -179.49 -160.70 -142.73
Net Income/Loss
78.77%
-36.16
-170.33 -179.49 -160.70 -142.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
56.70%
-0.944
-2.18 -2.489 -2.804 -2.576
Basic Average Shares
4,482%
178.71
3.9004 163.31 160.54 152.65
Diluted Average Shares
4,482%
178.71
3.9004 163.31 160.54 152.65
Basic Earnings Per Share
79.17%
-0.20
-0.96 -1.08 -0.98 -0.92
Diluted Earnings Per Share
79.17%
-0.20
-0.96 -1.08 -0.98 -0.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):